Schedule 13G ownership disclosure
Anavex Life Sciences Corp
Security class unavailable · CUSIP: 032797300
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,671,075
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086364-24-003825
- Form type
- SC 13G
- Filer
- ANAVEX LIFE SCIENCES CORP.
- CIK
- CIK 1314052
- Filed
- Jan 25, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership